DEXCOM INC Insider Trading for March 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in DEXCOM INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in DEXCOM INC for March 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 25 2016 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | S | 61.76 | 1,666 | 102,893 | 13,407 | 15.1 K to 13.4 K (-11.05 %) |
Mar 24 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | S | 59.51 | 25,000 | 1,487,750 | 276,064 | 301.1 K to 276.1 K (-8.30 %) |
Mar 15 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | D | 63.96 | 6,345 | 405,834 | 19,588 | 25.9 K to 19.6 K (-24.47 %) |
Mar 15 2016 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | D | 63.96 | 13,288 | 849,919 | 384,227 | 397.5 K to 384.2 K (-3.34 %) |
Mar 15 2016 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | D | 63.96 | 2,658 | 170,009 | 95,660 | 98.3 K to 95.7 K (-2.70 %) |
Mar 15 2016 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | D | 63.96 | 6,345 | 405,833 | 224,718 | 231.1 K to 224.7 K (-2.75 %) |
Mar 15 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | D | 63.96 | 4,430 | 283,348 | 75,984 | 80.4 K to 76 K (-5.51 %) |
Mar 15 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | S | 63.75 | 3,560 | 226,964 | 76,718 | 80.3 K to 76.7 K (-4.43 %) |
Mar 15 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | D | 63.96 | 3,102 | 198,408 | 80,278 | 83.4 K to 80.3 K (-3.72 %) |
Mar 15 2016 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | D | 63.96 | 4,430 | 283,348 | 123,022 | 127.5 K to 123 K (-3.48 %) |
Mar 15 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | D | 63.96 | 4,430 | 283,348 | 129,979 | 134.4 K to 130 K (-3.30 %) |
Mar 14 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | D | 63.18 | 8,040 | 507,967 | 134,409 | 142.4 K to 134.4 K (-5.64 %) |
Mar 14 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Sell | D | 63.18 | 3,328 | 210,263 | 142,449 | 145.8 K to 142.4 K (-2.28 %) |
Mar 14 2016 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | D | 63.18 | 16,633 | 1,050,873 | 397,515 | 414.1 K to 397.5 K (-4.02 %) |
Mar 14 2016 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | D | 63.18 | 12,254 | 774,208 | 414,148 | 426.4 K to 414.1 K (-2.87 %) |
Mar 14 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | D | 63.18 | 6,451 | 407,574 | 83,380 | 89.8 K to 83.4 K (-7.18 %) |
Mar 14 2016 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | D | 63.18 | 4,319 | 272,874 | 89,831 | 94.2 K to 89.8 K (-4.59 %) |
Mar 14 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | D | 63.18 | 15,690 | 991,294 | 477,328 | 493 K to 477.3 K (-3.18 %) |
Mar 14 2016 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | D | 63.18 | 8,076 | 510,242 | 127,452 | 135.5 K to 127.5 K (-5.96 %) |
Mar 14 2016 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | D | 63.18 | 3,328 | 210,263 | 135,528 | 138.9 K to 135.5 K (-2.40 %) |
Mar 14 2016 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | D | 63.18 | 5,992 | 378,575 | 98,318 | 104.3 K to 98.3 K (-5.74 %) |
Mar 14 2016 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | D | 63.18 | 1,988 | 125,602 | 104,310 | 106.3 K to 104.3 K (-1.87 %) |
Mar 14 2016 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | D | 63.18 | 8,126 | 513,401 | 231,063 | 239.2 K to 231.1 K (-3.40 %) |
Mar 14 2016 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | D | 63.18 | 4,725 | 298,526 | 239,189 | 243.9 K to 239.2 K (-1.94 %) |
Mar 14 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Buy | J | 65.15 | 8,334 | 542,960 | 80,414 | 72.1 K to 80.4 K (+11.56 %) |
Mar 14 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | D | 63.18 | 6,532 | 412,692 | 72,080 | 78.6 K to 72.1 K (-8.31 %) |
Mar 14 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | D | 63.18 | 3,321 | 209,821 | 78,612 | 81.9 K to 78.6 K (-4.05 %) |
Mar 14 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | J | 65.15 | 8,334 | 542,960 | 76,333 | 84.7 K to 76.3 K (-9.84 %) |
Mar 14 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | J | 65.15 | 11,937 | 777,696 | 25,933 | 14 K to 25.9 K (+85.29 %) |
Mar 14 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | D | 63.18 | 8,133 | 513,843 | 13,996 | 22.1 K to 14 K (-36.75 %) |
Mar 14 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | D | 63.18 | 4,725 | 298,526 | 22,129 | 26.9 K to 22.1 K (-17.60 %) |
Mar 14 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | J | 65.15 | 11,937 | 777,696 | 91,667 | 103.6 K to 91.7 K (-11.52 %) |
Mar 10 2016 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Grant | A | 0.00 | 38,000 | 38 | 138,856 | 100.9 K to 138.9 K (+37.68 %) |
Mar 10 2016 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Grant | A | 0.00 | 38,000 | 38 | 243,914 | 205.9 K to 243.9 K (+18.45 %) |
Mar 10 2016 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Grant | A | 0.00 | 30,000 | 30 | 106,298 | 76.3 K to 106.3 K (+39.32 %) |
Mar 10 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | J | 66.10 | 15,000 | 991,500 | 26,854 | 11.9 K to 26.9 K (+126.54 %) |
Mar 10 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | J | 66.10 | 11,833 | 782,161 | 11,854 | 21 to 11.9 K (+56,347.62 %) |
Mar 10 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | J | 66.10 | 15,000 | 991,500 | 103,604 | 118.6 K to 103.6 K (-12.65 %) |
Mar 10 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | J | 66.10 | 11,833 | 782,161 | 118,604 | 130.4 K to 118.6 K (-9.07 %) |
Mar 10 2016 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Grant | A | 0.00 | 38,000 | 38 | 130,437 | 92.4 K to 130.4 K (+41.11 %) |
Mar 10 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Buy | J | 66.10 | 13,334 | 881,377 | 81,933 | 68.6 K to 81.9 K (+19.44 %) |
Mar 10 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Buy | J | 66.10 | 8,333 | 550,811 | 68,599 | 60.3 K to 68.6 K (+13.83 %) |
Mar 10 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | J | 66.10 | 13,334 | 881,377 | 84,667 | 98 K to 84.7 K (-13.61 %) |
Mar 10 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | J | 66.10 | 8,333 | 550,811 | 98,001 | 106.3 K to 98 K (-7.84 %) |
Mar 10 2016 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Grant | A | 0.00 | 33,000 | 33 | 106,334 | 73.3 K to 106.3 K (+45.00 %) |
Mar 10 2016 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical, Regu ... | Grant | A | 0.00 | 38,000 | 38 | 145,777 | 107.8 K to 145.8 K (+35.26 %) |
Mar 10 2016 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Grant | A | 0.00 | 34,000 | 34 | 493,018 | 459 K to 493 K (+7.41 %) |
Mar 10 2016 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Grant | A | 0.00 | 90,000 | 90 | 426,402 | 336.4 K to 426.4 K (+26.75 %) |
Mar 08 2016 | DXCM | DEXCOM INC | KAHN BARBARA | Director | Sell | S | 67.04 | 5,000 | 335,216 | 45,804 | 50.8 K to 45.8 K (-9.84 %) |